Cargando…

A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap

Vascular endothelial growth factor (VEGF), through its activation of cell surface receptor tyrosine kinases including VEGFR1 and VEGFR2, is a vital regulator of stimulatory and inhibitory processes that keep angiogenesis – new capillary growth from existing microvasculature – at a dynamic balance in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Florence T. H., Stefanini, Marianne O., Mac Gabhann, Feilim, Popel, Aleksander S.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663039/ https://www.ncbi.nlm.nih.gov/pubmed/19352513 http://dx.doi.org/10.1371/journal.pone.0005108

Ejemplares similares

The Presence of VEGF Receptors on the Luminal Surface of Endothelial Cells Affects VEGF Distribution and VEGF Signaling
por: Stefanini, Marianne O., et al.
Publicado: (2009)

A compartment model of VEGF distribution in blood, healthy and diseased tissues
por: Stefanini, Marianne O, et al.
Publicado: (2008)

Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis
por: Vempati, Prakash, et al.
Publicado: (2011)

Targeting Neuropilin-1 to Inhibit VEGF Signaling in Cancer: Comparison of Therapeutic Approaches
por: Gabhann, Feilim Mac, et al.
Publicado: (2006)

A Two-Compartment Model of VEGF Distribution in the Mouse
por: Yen, Phillip, et al.
Publicado: (2011)

Quantifying the Proteolytic Release of Extracellular Matrix-Sequestered VEGF with a Computational Model
por: Vempati, Prakash, et al.
Publicado: (2010)

Computational Modeling of Interacting VEGF and Soluble VEGF Receptor Concentration Gradients
por: Hashambhoy, Yasmin L., et al.
Publicado: (2011)

Compartment Model Predicts VEGF Secretion and Investigates the Effects of VEGF Trap in Tumor-Bearing Mice
por: Finley, Stacey D., et al.
Publicado: (2013)

Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
por: Kut, C, et al.
Publicado: (2007)

Effects of Fiber Type and Size on the Heterogeneity of Oxygen Distribution in Exercising Skeletal Muscle
por: Liu, Gang, et al.
Publicado: (2012)

VEGF-A121a binding to Neuropilins – A concept revisited
por: Sarabipour, Sarvenaz, et al.
Publicado: (2017)

Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies
por: Finley, Stacey D, et al.
Publicado: (2011)

Computational Model of Vascular Endothelial Growth Factor Spatial Distribution in Muscle and Pro-Angiogenic Cell Therapy
por: Mac Gabhann, Feilim, et al.
Publicado: (2006)

Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
por: Bender, R. Joseph, et al.
Publicado: (2013)

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use
por: Wu, Florence T H, et al.
Publicado: (2010)

Systems Pharmacology of VEGF165b in Peripheral Artery Disease
por: Clegg, Lindsay E., et al.
Publicado: (2017)

Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation
por: Tan, Wan Hua, et al.
Publicado: (2013)

Expression of VEGF Receptors on Endothelial Cells in Mouse Skeletal Muscle
por: Imoukhuede, Princess I., et al.
Publicado: (2012)

A systems biology view of blood vessel growth and remodelling
por: Logsdon, Elizabeth A, et al.
Publicado: (2014)

Module-based multiscale simulation of angiogenesis in skeletal muscle
por: Liu, Gang, et al.
Publicado: (2011)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis
por: Bender, R. Joseph, et al.
Publicado: (2015)

Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
por: Stewart, Michael W
Publicado: (2012)

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts
por: Dore-Savard, Louis, et al.
Publicado: (2016)

Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2012)

A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands
por: Clegg, Lindsay E., et al.
Publicado: (2017)

Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer
por: Zhao, Chen, et al.
Publicado: (2015)

TILRR Steers Interleukin-1 Signaling: Co-Receptor Provides Context and a Therapeutic Target
por: Mac Gabhann, Feilim
Publicado: (2017)

VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor
por: Favara, David M, et al.
Publicado: (2014)

Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors
por: Michaloski, Jussara S., et al.
Publicado: (2016)

Analysis of VEGF-A Regulated Gene Expression in Endothelial Cells to Identify Genes Linked to Angiogenesis
por: Rivera, Corban G., et al.
Publicado: (2011)

The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
por: Lieu, Christopher H., et al.
Publicado: (2013)

Computer Simulation of TSP1 Inhibition of VEGF–Akt–eNOS: An Angiogenesis Triple Threat
por: Bazzazi, Hojjat, et al.
Publicado: (2018)

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
por: Zajkowska, Monika, et al.
Publicado: (2018)

Expression and characterization of a soluble VEGF receptor 2 protein
por: Liu, Wei, et al.
Publicado: (2014)

Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1
por: Luo, Ling, et al.
Publicado: (2013)

A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF(165b) in peripheral arterial disease in human and mouse
por: Chu, Liang-Hui, et al.
Publicado: (2016)

Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model
por: Clegg, Lindsay Wendel, et al.
Publicado: (2015)

Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes
por: Marks, Edward C. A., et al.
Publicado: (2018)

Multi-Scale Modeling of HIV Infection in vitro and APOBEC3G-Based Anti-Retroviral Therapy
por: Hosseini, Iraj, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_09kkp4nhb0fs3tohv5sus9hjq9